Results 261 to 270 of about 7,177,989 (337)

Epigenetic Reactivation of TNFRSF19 Suppresses Mitophagy and Sensitizes Triple‐Negative Breast Cancer to Doxorubicin

open access: yesAdvanced Science, Volume 13, Issue 64, 16 November 2026.
TNFRSF19 is an epigenetically silenced regulator of mitophagy in triple‐negative breast cancer. TNFRSF19 deficiency activates the TGFBR1–SMAD3–PINK1 axis to promote mitophagy and confer doxorubicin resistance, whereas decitabine‐mediated restoration of TNFRSF19 suppresses mitophagy and enhances doxorubicin sensitivity, revealing a targetable epigenetic–
Shiyang Liu   +7 more
wiley   +1 more source

Early detection of esophageal squamous cell carcinoma via a CACNA1E-SNTG1 cfDNA methylation signature. [PDF]

open access: yesClin Epigenetics
Song C   +12 more
europepmc   +1 more source

Return‐To‐Work and Working Status After Surgery for Gastric and Esophageal Cancer: A Prospective Observational Study

open access: yesAnnals of Gastroenterological Surgery, Volume 10, Issue 6, Page 1732-1742, November 2026.
In this multicenter prospective study of 158 working‐age patients undergoing curative‐intent surgery for gastric or esophageal cancer, 78.5% were working at 18 months. Postoperative appetite loss, financial difficulties, and ≥ 10% weight loss at 6 months were associated with non‐working status.
Kentaro Goto   +18 more
wiley   +1 more source

Developing Machine Learning‐Based Prognostic Models for Nonmelanoma Skin Cancer Patients With Comorbid Diabetes: A Retrospective Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Nonmelanoma skin cancer (NMSC) is one of the most common malignancies worldwide, with increasing incidence. Type 2 diabetes mellitus (T2DM) is a prevalent comorbidity that may adversely affect cancer prognosis through shared metabolic and inflammatory pathways.
Junjie Huang   +8 more
wiley   +1 more source

Real‐World Validation of the MAGIC‐D Index in Unresectable Biliary Tract Cancer Treated With Durvalumab Plus Chemotherapy

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
Real‐world Validation of the MAGIC‐D Index. The MAGIC‐D index was validated using real‐world data from patients with unresectable BTC who received durvalumab‐chemotherapy at Tongji Hospital. The risk stratification ability of the MAGIC‐D index for patient survival was improved after incorporating Ki67 and CA 19‐9.
Tianao Zhan   +9 more
wiley   +1 more source

METTL7B‐Mediated m6A Modification of PLEKHA4 Suppresses Ferroptosis via Reducing AURKA Ubiquitination to Promote Papillary Thyroid Cancer Progression

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
In PTC cells, METTL7B stabilizes PLEKHA4 mRNA through m6A modification; upregulated PLEKHA4 binds KLHL12 and inhibits KLHL12‐mediated ubiquitination and degradation of AURKA, thereby stabilizing AURKA protein. Elevated AURKA suppresses ferroptosis by upregulating GPX4 and xCT while downregulating ACSL4, leading to ferroptosis resistance and enhanced ...
Wei Lin   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy